Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization: ikenaoncology.com (IMA)
ImageneBio Inc (IMA) develops targeted anti-tumor therapies with a complex component supply chain, while high development costs and strict regulatory oversight limit entry into this sector. This price chart shows that EV/EBITDA is 0.00. The business relies on immuno-oncology, where the uncertainty of new projects is offset by venture capital and the introduction of drugs for various diagnoses.
IMA (ikenaoncology.com): analytical breakdowns and indicator data
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book value of equity indicators:
- debt level and financial liquidity data:
- net income and valuation multiples indicators:
IMA - Annual Net Income|Projected Future Earnings ImageneBio Inc|IMA - Market Cap to Earnings|Future Price to Earnings Ikena Oncology|IMA - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple IMA|IMA - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Ikena Oncology|IMA - Earnings per share for the last twelve months|Quarterly EPS earnings growth ikenaoncology.com|IMA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year ImageneBio Inc
Comprehensive company analysis:IMA (Ikena Oncology, Inc.)
For long-term risk management, it is critical to track the ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA valuation level, an investor can determine the extent to which the asset value of ImageneBio Inc (IMA) is justified by current efficiency, which, given the capital burn and hypothetical pipeline payback, indicates the company's high vulnerability to changes in the cost of debt financing.
Competitors of ImageneBio Inc (IMA)
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Argenx ARGX|BNTX - Enterprise Value to EBITDA Ratio|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|PTGX (Protagonist) - Enterprise Value to EBITDA Ratio|Immunovant Inc (IMVT) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kiniksa Pharmaceuticals Ltd|Enterprise Value to Operating Income Before Depreciation GRFS (Grifols Biemat)|EV/EBITDA Multiple ADPT|CLDX - Company Value to EBITDA|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|Total Company Value to Operating Income Before Depreciation Ratio BioCryst Pharmaceuticals, Inc. (BCRX)|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Dianthus Corp (DNTH) - Enterprise Value to EBITDA Ratio|PHVS: EV/EBITDA Multiple|AbCellera (ABCL) - EV/EBITDA Multiple|TRML (Tourmaline Bio) - EV/EBITDA Multiple|PGEN - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple PHAR|NKTR - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|ZBIO: Enterprise Value to Operating Income Before Depreciation|Immunome - EV/EBITDA Multiple|Company Value to EBITDA Gossamer Bio Inc|KALV: EV/EBITDA Multiple|SEPN (Septerna Pharma) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Company Value to EBITDA|Astria Pharma - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENGN|RAPT Therapeutics - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation KYTX|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cabaletta Bio Inc (CABA)|EV/EBITDA Multiple VTYX|Total Company Value to Operating Income Before Depreciation Ratio theratech.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN - Enterprise Value to EBITDA Ratio|Agenus Inc - EV/EBITDA Multiple|CLYM - EV/EBITDA Multiple|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ATYR (atyrpharma.com)|ADAG (Adagene Inc) - EV/EBITDA Multiple|STTK: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple EQ|EV/EBITDA Multiple connectbiopharm.com (CNTB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|Business Value to Operating Income Before Depreciation ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to Operating Income Before Depreciation XTLB (XTL Bio)|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XRTX: EV/EBITDA Multiple|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|INDP - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple SCNI|CALI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK: Enterprise Value to Operating Income Before Depreciation|HOOKIPA - EV/EBITDA Multiple|Company Value to EBITDA IGM Biosciences, Inc.|ITOS: EV/EBITDA Multiple|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
